Cargando…

Association between immunosuppressants and poor antibody responses to SARS-CoV-2 vaccines in patients with autoimmune liver diseases

The antibody and B cell responses after inactivated SARS-CoV-2 vaccination have not been well documented in patients with autoimmune liver disease (AILD). Therefore, we conducted a prospective observational study that included AILD patients and healthy participants as controls between July 1, 2021,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hu, Wang, Yuting, Ao, Ling, Ke, Mingxia, Chen, Zhiwei, Chen, Min, Peng, Mingli, Ling, Ning, Hu, Peng, Cai, Dachuan, Zhang, Dazhi, Ren, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579272/ https://www.ncbi.nlm.nih.gov/pubmed/36275639 http://dx.doi.org/10.3389/fimmu.2022.988004

Ejemplares similares

Association between immunosuppressants and poor antibody responses to inactivated SARS-CoV-2 vaccines in patients with autoimmune liver diseases
por: Li, Hu, et al.
Publicado: (2022)

Decreased antibody response to influenza vaccine with an enhanced antibody response to subsequent SARS‐CoV‐2 vaccination in patients with chronic hepatitis B virus infection
por: He, Taiyu, et al.
Publicado: (2022)

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV
por: Ao, Ling, et al.
Publicado: (2022)

A Comprehensive Hepatitis B Surface Antigen-Positive Patient-Centered Screening and Linkage to Care Strategies Targeting Microelimination of Hepatitis C Virus Infection in Chongqing, China
por: Cai, Dachuan, et al.
Publicado: (2022)

Dynamic change in Siglec-15 expression in peritumoral macrophages confers an immunosuppressive microenvironment and poor outcome in glioma
por: Chen, Quan, et al.
Publicado: (2023)

Tenascin-C can Serve as an Indicator for the Immunosuppressive Microenvironment of Diffuse Low-Grade Gliomas
por: Zhang, Po, et al.
Publicado: (2022)

Advances in Autoimmune Epilepsy Associated with Antibodies, Their Potential Pathogenic Molecular Mechanisms, and Current Recommended Immunotherapies
por: Fang, Zhiwei, et al.
Publicado: (2017)

Immunosuppression Reversal Nanovaccines Substituting Dendritic Cells for Personalized Cancer Immunotherapy
por: Chen, Hu, et al.
Publicado: (2022)

Editorial: Immunometabolism of T cells in skin infection, autoimmunity and cancer biology
por: Peng, Lu, et al.
Publicado: (2023)

Cancer risks in rheumatoid arthritis patients who received immunosuppressive therapies: Will immunosuppressants work?
por: Zhang, Yuzhuo, et al.
Publicado: (2022)

Humoral immune responses to inactivated COVID-19 vaccine up to 1 year in children with chronic hepatitis B infection
por: Zhou, Yingzhi, et al.
Publicado: (2023)

Modulation of immunosuppressive cells and noncoding RNAs as immunotherapy in osteosarcoma
por: Xia, Yidan, et al.
Publicado: (2022)

The Antibody Assay in Suspected Autoimmune Encephalitis From Positive Rate to Test Strategies
por: Deng, Qun, et al.
Publicado: (2022)

Coexistence of multiple anti-neuronal antibodies in autoimmune encephalitis in China: A multi-center study
por: Qiao, Shan, et al.
Publicado: (2022)

CCND1 Amplification Contributes to Immunosuppression and Is Associated With a Poor Prognosis to Immune Checkpoint Inhibitors in Solid Tumors
por: Chen, Yu, et al.
Publicado: (2020)

CCND1 Amplification Profiling Identifies a Subtype of Melanoma Associated With Poor Survival and an Immunosuppressive Tumor Microenvironment
por: Liu, Jun, et al.
Publicado: (2022)

Standard immunosuppressive treatment reduces regulatory B cells in children with autoimmune liver disease
por: Yuksel, Muhammed, et al.
Publicado: (2023)

Type I interferon score is associated with the severity and poor prognosis in anti-MDA5 antibody-positive dermatomyositis patients
por: Qian, Jinjing, et al.
Publicado: (2023)

Sublingual Bacterial Vaccination Reduces Recurrent Infections in Patients With Autoimmune Diseases Under Immunosuppressant Treatment
por: Sánchez-Ramón, Silvia, et al.
Publicado: (2021)

Roles of IL-25 in Type 2 Inflammation and Autoimmune Pathogenesis
por: Deng, Chong, et al.
Publicado: (2021)

Vaccination in Children With Autoimmune Disorders and Treated With Various Immunosuppressive Regimens: A Comprehensive Review and Practical Guide
por: Blanchard-Rohner, Geraldine
Publicado: (2021)

KMCP: accurate metagenomic profiling of both prokaryotic and viral populations by pseudo-mapping
por: Shen, Wei, et al.
Publicado: (2022)

Head-to-head comparisons of the neutralizing antibody against SARS-CoV-2 variants elicited by four priming-boosting regimens
por: Jiang, Hu-Dachuan, et al.
Publicado: (2022)

Prognostic significance of psoas muscle index in male hepatocellular carcinoma patients treated with immune checkpoint inhibitors and tyrosine kinase inhibitors
por: Luo, Ning, et al.
Publicado: (2023)

Enhanced Functions of Peripheral γδ T Cells in Chronic Hepatitis B Infection during Interferon α Treatment In Vivo and In Vitro
por: Chen, Min, et al.
Publicado: (2015)

Waning humoral immune responses to inactivated SARS-CoV-2 vaccines in patients with severe liver disease
por: Chen, Zhiwei, et al.
Publicado: (2022)

Association between human leukocyte antigen and immunosuppressive treatment outcomes in Chinese patients with aplastic anemia
por: Chen, Lingyun, et al.
Publicado: (2023)

GAD65 Antibody Epitopes and Genetic Background in Latent Autoimmune Diabetes in Youth (LADY)
por: Peng, Yiman, et al.
Publicado: (2022)

Characteristics of Anti-Contactin1 Antibody-Associated Autoimmune Nodopathies With Concomitant Membranous Nephropathy
por: Xu, Qianhui, et al.
Publicado: (2021)

Bracovirus Sneaks Into Apoptotic Bodies Transmitting Immunosuppressive Signaling Driven by Integration-Mediated eIF5A Hypusination
por: Zhou, Gui-Fang, et al.
Publicado: (2022)

Heterogeneity of antibody-secreting cells infiltrating autoimmune tissues
por: Giovannini, Diane, et al.
Publicado: (2023)

CD4+ T Cell Help Is Mandatory for Naive and Memory Donor-Specific Antibody Responses: Impact of Therapeutic Immunosuppression
por: Chen, Chien-Chia, et al.
Publicado: (2018)

Epidemiology of Antibody-Positive Autoimmune Encephalitis in Southwest China: A Multicenter Study
por: Gu, Yixue, et al.
Publicado: (2019)

The Effect of Immunosuppressive Adjuvant Kynurenine on Type 1 Diabetes Vaccine
por: Sun, Jing, et al.
Publicado: (2021)

The m(6)A-related gene signature stratifies poor prognosis patients and characterizes immunosuppressive microenvironment in hepatocellular carcinoma
por: Ma, Ensi, et al.
Publicado: (2023)

Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody
por: Bai, Yunfei, et al.
Publicado: (2023)

The immunosuppressive microenvironment and immunotherapy in human glioblastoma
por: Zhang, Xuehua, et al.
Publicado: (2022)

Performance of the clinical assessment scale for autoimmune encephalitis in a pediatric autoimmune encephalitis cohort
por: Zhou, Hao, et al.
Publicado: (2022)

Editorial: Improve metabolic and autoimmune diseases by regulating gut microbiota
por: Kang, Yongbo, et al.
Publicado: (2022)

Systemic lupus erythematosus is causally associated with hypothyroidism, but not hyperthyroidism: A Mendelian randomization study
por: Qin, Qiong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_686ltrae8n4jmbob9i59t4jf3r